ABG
SYRS
Ally Bridge Group’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-249,126
| Closed | -$665K | – | 22 |
|
|
2023
Q1 | $665K | Sell |
249,126
-619,277
| -71% | -$1.65M | 0.87% | 18 |
|
|
2022
Q4 | $3.12M | Hold |
868,403
| – | – | 3.03% | 14 |
|
|
2022
Q3 | $5.59M | Sell |
868,403
-2,496,492
| -74% | -$16.1M | 3.69% | 11 |
|
|
2022
Q2 | $3.24M | Hold |
3,364,895
| – | – | 2.95% | 15 |
|
|
2022
Q1 | $4M | Sell |
3,364,895
-175,000
| -5% | -$208K | 2.97% | 15 |
|
|
2021
Q4 | $11.5M | Buy |
3,539,895
+100,000
| +3% | +$326K | 4.03% | 9 |
|
|
2021
Q3 | $15.4M | Hold |
3,439,895
| – | – | 4.52% | 7 |
|
|
2021
Q2 | $18.7M | Buy |
3,439,895
+300,000
| +10% | +$1.63M | 4.66% | 4 |
|
|
2021
Q1 | $23.5M | Buy |
3,139,895
+497,395
| +19% | +$3.72M | 4.5% | 4 |
|
|
2020
Q4 | $28.7M | Buy |
+2,642,500
| New | +$28.7M | 4.91% | 4 |
|